ReviewResearch and practice in thrombosis and haemostasis2019
Pulmonary embolism response teams: Purpose, evidence for efficacy, and future research directions.
Review in Research and practice in thrombosis and haemostasis, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
45 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- The use of Veno-arterial Extracorporeal Membrane Oxygenation (VA-ECMO) for Acute High Risk Pulmonary Embolism: A Systematic Review.Current cardiology reviews · 2025Pooled it
- Impact of pulmonary embolism response teams on acute pulmonary embolism: a systematic review and meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2022Pooled it
- Role of Pulmonary Embolism Response Team in patients with intermediate- and high-risk pulmonary embolism: a concise review and preliminary experience from China.Journal of geriatric cardiology : JGC · 2020Pooled it
- Reconsidering the default: should surgical pulmonary embolectomy have a larger role in high-risk pulmonary embolism at experienced centres?Journal of thoracic disease · 2026Article
- Impact of a pulmonary embolism response team on the management of acute pulmonary embolism: a retrospective observational study.Research and practice in thrombosis and haemostasis · 2026Article
- Prognostic Significance of Echocardiography-Visualized Thrombus in Right Heart in Early Stages of Acute PE: 100 Patients from Regional Pulmonary Embolism Registry.Life (Basel, Switzerland) · 2026Article
- Association of left ventricular outflow tract velocity-time integral with severity of pulmonary embolism in patients treated with catheter-directed therapies.Journal of thrombosis and thrombolysis · 2026Article
- Advances in cellular and molecular mechanisms of trauma-induced organ inflammation and dysfunction.Burns & trauma · 2026Review
- Persistent Right Ventricular Dysfunction and Hemodynamic Evolution Predict In-Hospital Deterioration in Intermediate-High- and High-Risk Pulmonary Embolism.Arquivos brasileiros de cardiologia · 2026Article
- Development, Implementation, and Evaluation of a Pediatric Pulmonary Embolism Clinical Pathway and Pulmonary Embolism Response Team.Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies · 2025Observational
- Impact of an Artificial Intelligence-Guided Pulmonary Embolism Response Team (AIPERT) on Patient Transfers, Diagnosis, and Management: A Healthcare System Experience.Clinics and practice · 2025Article
- Clinical utility of artificial intelligence models in radiology: a systemic scoping review of diagnostic and endovascular applications.CVIR endovascular · 2025Review
- Process and outcome evaluation of a regional pulmonary embolism response team.Thrombosis journal · 2025Article
- Article
- Refining Pulmonary Embolism Management: Balancing Innovation with Accuracy.American journal of respiratory and critical care medicine · 2025Article
- The Need for a Multidisciplinary Approach for Successful High-Risk Pulmonary Embolism Treatment.Federal practitioner : for the health care professionals of the VA, DoD, and PHS · 2025Article
- Rationale and design of the PE-TRACT trial: A multicenter randomized trial to evaluate catheter-directed therapy for the treatment of intermediate-risk pulmonary embolism.American heart journal · 2025Article
- Mechanical Thrombectomy for Acute Pulmonary Embolism in Non-Operating Room Anesthesia (NORA) Locations: Best Safety Practices and Local Insights.Healthcare (Basel, Switzerland) · 2025Review
- Time trends of catheter-directed treatment in acute pulmonary embolism in Germany.Research and practice in thrombosis and haemostasis · 2025Article
- Pulmonary Embolism Response Teams-Evidence of Benefits? A Systematic Review and Meta-Analysis.Journal of clinical medicine · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pulmonary embolism (PE) is a major cause of morbidity and mortality in the United States. Although new therapeutic tools and strategies have recently been developed for the diagnosis and treatment of patients with PE, the outcomes for patients who present with massive or high-risk PE remain dismal. To address this crisis, pulmonary embolism response teams (PERTs) are being created around the world in an effort to immediately and simultaneously engage multiple specialists to determine the best course of action and coordinate the clinical care for patients with acute PE. The scope of this review is to describe the PERT model and purpose, present the structure and organization, examine the available evidence for efficacy and usefulness, and propose future directions for research that is needed to demonstrate the value of PERT and determine if this multidisciplinary approach represents a new standard of care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.